日本人集団における70遺伝子MammaPrintプロファイルの検証

基本情報

NCT ID

NCT00904566

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

102

治験依頼者名

Agendia

概要

By using gene-expression profiling, Van't Veer and colleagues developed a 70-gene prognosis profile, MammaPrint, to identify breast cancer patients who are at low risk of developing distant metastases and therefore might safely be spared chemotherapy. The aim of this study is to evaluate the prognostic value of the 70-gene Mammaprint profile in Japanese women with node-negative breast cancer.

対象疾患

依頼者（Sponsor）

実施施設 (1)